wondering what consensus is on leerink biopharma? huge growth in the last couple years, ecm ranked number 1. is it effectively an eb for the industry at this point? where does it rank
| +103 | [2026 - October] Unbiased Prestige Rankings | 61 | 18h |
| +94 | Who is the final boss in Houston Energy? (GS, JEFF or EVR) | 36 | 13h |
| +84 | You should probably leave IB | 28 | 20h |
| +47 | Why Do We Turn Comments? | 11 | 1d |
| +46 | Tomorrow Will Be Better | 5 | 5d |
| +41 | Moelis PCA vs Lower tier BB Coverage | 32 | 9h |
| +34 | Banking (Un)fortunately Still Needs You: My Case for Bankers in the AI Era | 9 | 14h |
| +29 | UBS Catastrophic Q1-Q3 26, M&A -17%, Outside Top 10 in Americas, EMEA & APAC | 4 | 1h |
| +28 | UBS IB #24 in US M&A in 2026 | 10 | 1d |
| +27 | Lateraling as Analyst | 25 | 1d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Based on the most helpful WSO content, Leerink has shown significant growth in recent years, particularly in the biopharma and healthcare sectors. It has been noted for its strong performance in ECM (Equity Capital Markets), even being ranked number one in this area. However, whether it is considered an Elite Boutique (EB) is still up for debate.
While Leerink's growth is impressive, and it is a top destination for those focusing on healthcare and life sciences, there is skepticism about whether it can consistently compete for $10+ billion M&A deals, a hallmark of true EBs. Comparisons to firms like Qatalyst in healthcare (HC) have been made, but achieving that level is seen as a tough challenge.
In terms of ranking, Leerink is certainly regarded as a top-end shop for healthcare, making it a strong platform for future opportunities in private equity (PE), growth equity (GE), and venture capital (VC) recruiting, especially in life sciences.
Sources: Is Leerink Turning Into EB?, Is Leerink Turning Into EB?, Is SVB Leerink Becoming an EB?, What's your Top Stock Pick for 2017
would recommend taking a look at these two threads on WSO.
[Early 2026] The Definitive and Data-Driven Healthcare IB Group Rankings (Biopharma + Broader HC)
Leerink Partners Culture?
Culture is very tough. Good luck.
It’s “Leerink”, good luck
Aut architecto quis unde pariatur officia rerum illum. Molestias eligendi aut rem. Eligendi et doloribus vel quis asperiores illo natus eos. Explicabo modi et iure est non laudantium.
Odit ut dolor quia error distinctio eius. Et aliquam at impedit nihil ab eveniet ut. Ut sit excepturi laudantium illo assumenda beatae quia.
Hic at dignissimos dolorem illo aliquam. Ipsa sit et nemo voluptas quisquam. Rerum quia explicabo reprehenderit dolorem ullam quo deleniti autem. Rerum facere non alias omnis perferendis. Minus ea rerum aspernatur expedita animi.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...